Delivery Order SPE2DB24D2101-SPE2DB25FKMPK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,139.70 to AmerisourceBergen Drug Corp for 250 mg vials of Orencia, a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. Issued on August 4, 2025, with an ultimate completion date of August 5, 2025, this firm fixed-price delivery order was awarded competitively without set-aside restrictions. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency has awarded a delivery order valued at $17,135.28 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price, competitively awarded contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is unencumbered by...
- The Defense Logistics Agency awarded a delivery order valued at $4,290.07 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Orencia 250 mg vials, a biologic immunosuppressant medication used primarily for rheumatoid arthritis treatment. This firm fixed price delivery order, valued at $6,942.46, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 26, 2025. The award was placed with AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $53,090.30 delivery order to AmerisourceBergen Drug Corp for 250 mg vials of Orencia, a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive set-aside contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $11,814.85 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and was awarded competitively without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $5,061.00 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price contract was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025, and represents a non-set-aside competitive award. The delivery order is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,362.12 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials. This firm fixed price contract, issued on August 22, 2025, represents a non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Orencia is a biologic immunosuppressant medication commonly used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Orencia 250 mg vials, a biologic medication used primarily for rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, valued at $5,478.63, is scheduled for completion by April 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order is valued at $13,647.57 with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation and was competitively awarded through the federal procurement process. The place of...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMPKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,855.88 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, and represents performance from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor under this global contract vehicle, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's track record of competitively awarded federal contracts across multiple therapeutic domains demonstrates its capability to meet the Defense Logistics Agency's exacting procurement standards for specialized pharmaceutical products supporting military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/22/25 |